Credit Suisse Ag Instil Bio, Inc. Transaction History

Credit Suisse Ag

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.48 - $5.33 $187 - $2,078	-390 Reduced 99.24%	3 $0
Q3 2022 Nov 10, 2022	BUY	$4.65 - $7.37 $1,534 - $2,432	330 Added 523.81%	393 $2,000
Q2 2022 Aug 12, 2022	BUY	$4.21 - $11.15 $265 - $702	63 New	63 $0

1.9M

Ticker TIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,694,000
Market Cap $2.67B
Description
Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small ce...

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.